SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-305708
Filing Date
2020-11-30
Accepted
2020-11-30 17:03:02
Documents
10
Effectiveness Date
2020-11-30

Document Format Files

Seq Description Document Type Size
1 S-8 d51479ds8.htm S-8 74565
2 EX-4.1 d51479dex41.htm EX-4.1 12071
3 EX-5.1 d51479dex51.htm EX-5.1 9419
4 EX-23.1 d51479dex231.htm EX-23.1 9928
5 EX-99.1 d51479dex991.htm EX-99.1 601413
6 GRAPHIC g51479dsp11.jpg GRAPHIC 3752
7 GRAPHIC g51479dsp12.jpg GRAPHIC 2288
8 GRAPHIC g51479g15v60.jpg GRAPHIC 434948
9 GRAPHIC g51479g16w02.jpg GRAPHIC 181975
10 GRAPHIC g51479st1.jpg GRAPHIC 6553
  Complete submission text file 0001193125-20-305708.txt   1576167
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-251033 | Film No.: 201358799
SIC: 2834 Pharmaceutical Preparations